143 related articles for article (PubMed ID: 15450817)
1. High-throughput methods for measuring heparanase activity and screening potential antimetastatic and anti-inflammatory agents.
Huang KS; Holmgren J; Reik L; Lucas-McGady D; Roberts J; Liu CM; Levin W
Anal Biochem; 2004 Oct; 333(2):389-98. PubMed ID: 15450817
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeled heparan sulfate immobilized on microplate as substrate for the detection of heparanase activity.
Nardella C; Steinkühler C
Anal Biochem; 2004 Sep; 332(2):368-75. PubMed ID: 15325306
[TBL] [Abstract][Full Text] [Related]
3. Heparanase activity in cultured endothelial cells.
Godder K; Vlodavsky I; Eldor A; Weksler BB; Haimovitz-Freidman A; Fuks Z
J Cell Physiol; 1991 Aug; 148(2):274-80. PubMed ID: 1880155
[TBL] [Abstract][Full Text] [Related]
4. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
[TBL] [Abstract][Full Text] [Related]
5. Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate.
Escobar Galvis ML; Jia J; Zhang X; Jastrebova N; Spillmann D; Gottfridsson E; van Kuppevelt TH; Zcharia E; Vlodavsky I; Lindahl U; Li JP
Nat Chem Biol; 2007 Dec; 3(12):773-8. PubMed ID: 17952066
[TBL] [Abstract][Full Text] [Related]
6. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I
J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
[TBL] [Abstract][Full Text] [Related]
7. A simple and rapid assay for heparanase activity using homogeneous time-resolved fluorescence.
Enomoto K; Okamoto H; Numata Y; Takemoto H
J Pharm Biomed Anal; 2006 Jun; 41(3):912-7. PubMed ID: 16495030
[TBL] [Abstract][Full Text] [Related]
8. Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells.
McKenzie E; Young K; Hircock M; Bennett J; Bhaman M; Felix R; Turner P; Stamps A; McMillan D; Saville G; Ng S; Mason S; Snell D; Schofield D; Gong H; Townsend R; Gallagher J; Page M; Parekh R; Stubberfield C
Biochem J; 2003 Jul; 373(Pt 2):423-35. PubMed ID: 12713442
[TBL] [Abstract][Full Text] [Related]
9. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
10. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass.
Kram V; Zcharia E; Yacoby-Zeevi O; Metzger S; Chajek-Shaul T; Gabet Y; Müller R; Vlodavsky I; Bab I
J Cell Physiol; 2006 Jun; 207(3):784-92. PubMed ID: 16514606
[TBL] [Abstract][Full Text] [Related]
11. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity.
Parish CR; Freeman C; Brown KJ; Francis DJ; Cowden WB
Cancer Res; 1999 Jul; 59(14):3433-41. PubMed ID: 10416607
[TBL] [Abstract][Full Text] [Related]
12. Heparanase involvement in physiology and disease.
Nasser NJ
Cell Mol Life Sci; 2008 Jun; 65(11):1706-15. PubMed ID: 18425416
[TBL] [Abstract][Full Text] [Related]
13. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
14. Ultrafiltration-based assay for heparanase activity.
Tsuchida S; Podyma-Inoue KA; Yanagishita M
Anal Biochem; 2004 Aug; 331(1):147-52. PubMed ID: 15246007
[TBL] [Abstract][Full Text] [Related]
15. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfate endoglycosidase and metastatic potential in murine fibrosarcoma and melanoma.
Ricoveri W; Cappelletti R
Cancer Res; 1986 Aug; 46(8):3855-61. PubMed ID: 3731061
[TBL] [Abstract][Full Text] [Related]
17. Heparanase upregulation in high glucose-treated endothelial cells is prevented by insulin and heparin.
Han J; Woytowich AE; Mandal AK; Hiebert LM
Exp Biol Med (Maywood); 2007 Jul; 232(7):927-34. PubMed ID: 17609509
[TBL] [Abstract][Full Text] [Related]
18. Heparanase in glomerular diseases.
van den Hoven MJ; Rops AL; Vlodavsky I; Levidiotis V; Berden JH; van der Vlag J
Kidney Int; 2007 Sep; 72(5):543-8. PubMed ID: 17519955
[TBL] [Abstract][Full Text] [Related]
19. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
Zhao H; Liu H; Chen Y; Xin X; Li J; Hou Y; Zhang Z; Zhang X; Xie C; Geng M; Ding J
Cancer Res; 2006 Sep; 66(17):8779-87. PubMed ID: 16951194
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity.
Benezra M; Ishai-Michaeli R; Ben-Sasson SA; Vlodavsky I
J Cell Physiol; 2002 Sep; 192(3):276-85. PubMed ID: 12124773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
